Table 2.
The frequency of HIV-1 drug resistance mutations among the participants
| Drug resistance mutations | Total (%) | HIV-1 Strain types | |
|---|---|---|---|
| CRF08_BC (%) | Others (%) | ||
| NRTIs | |||
| M41L | 2 (0.6) | 2 (0.6) | 0 |
| A62V | 1 (0.3) | 1 (0.3) | 0 |
| K65KR | 5 (1.5) | 4 (1.2%) | 1 (0.3) |
| D67DN | 2 (0.6) | 2 (0.6) | 0 |
| T69D | 1 (0.3) | 1 (0.3) | 0 |
| V75VI | 1 (0.3) | 0 | 1 (0.3) |
| T215D | 1 (0.3) | 1 (0.3) | 0 |
| NNRTIs | |||
| K101E | 3 (0.9) | 2 (0.6) | 1 (0.3) |
| K103N/KN/KQR | 3 (0.9) | 3 (0.9) | 0 |
| V106I/VI | 9 (2.8) | 5 (1.6) | 4 (1.2%) |
| E138A/EA/G/EG/K/R | 46 (14.3) | 45 (14.0) | 1 (0.3) |
| V179E/T/D/DE/VD/VDE | 44 (13.7) | 28 (8.7) | 16 (5.0) |
| Y188L/N/YC/YF | 4 (1.2) | 4 (1.2%) | 0 |
| G190A | 1 (0.3) | 1 (0.3) | 0 |
| H221Y/HY | 3 (0.9) | 1 (0.3) | 2 (0.6) |
| P225H | 3 (0.9) | 3 (0.9) | 0 |
| PIs | |||
| D30DN | 1 (0.3) | 1 (0.3) | 0 |
| I47IV | 1 (0.3) | 1 (0.3) | 0 |
| I50IV | 1 (0.3) | 0 | 1 (0.3) |
| V82VL | 1 (0.3) | 1 (0.3) | 0 |
| PR Accessory | |||
| K20T | 1 (0.3) | 1 (0.3) | 0 |
| L24LF | 1 (0.3) | 1 (0.3) | 0 |
| V32LV | 1 (0.3) | 0 | 1 (0.3) |
| L33F | 1 (0.3) | 0 | 1 (0.3) |
| I47IK | 1 (0.3) | 0 | 1 (0.3) |
| G48GE | 1 (0.3) | 1 (0.3) | 0 |
| I50IT | 1 (0.3) | 1 (0.3) | 0 |
| Q58QE | 1 (0.3) | 1 (0.3) | 0 |
| I84IK | 1 (0.3) | 1 (0.3) | 0 |
| L89MV | 1 (0.3) | 0 | 1 (0.3) |